> High-Concurrency Ingestion: Scale to 1TB/hour and 5,000 Instruments and Beyond
Modern biopharma doesn’t have a data problem—it has a data movement and usability problem.
In many organizations, instruments generate high-value scientific outputs continuously, but the enterprise pipeline can’t keep up. Data arrives late. Context gets lost. Scientists resort to copying files, renaming folders, and rebuilding lineage in spreadsheets.
When small inefficiencies repeat across thousands of instruments, they become enterprise-scale drag.
In Part 1 of the white paper series, this paper reframes the challenge at fleet scale. The strategic objective is not simply “move files.” It is to convert continuous instrument output into governed digital assets—consistently, at scale.
Fleet-scale ingestion establishes the operational foundation. But scale does not increase in only one direction.
As scientific programs advance, individual assets grow from gigabytes to terabytes. In parallel, structured datasets expand from thousands of files to hundreds of thousands. These pressures introduce distinct operational requirements beyond concurrency alone.
Those dimensions are addressed in the subsequent papers in the series:
→ Part 2: High-Content Screening: Scale to 5 TB/file and Beyond, which examines reliability, resumability, and integrity evidence when a single scientific asset reaches multi-terabyte scale.
→ Part 3: High-Throughput Sciences: Scale to 250,000 Files/Dataset and Beyond, which defines determinism, completeness, and governance when object counts reach extreme scale.
What You’ll Get in the Full Paper
- Proven scaling benchmark for sustained, error-free ingestion at enterprise volume
- Architecture patterns enabling high-concurrency ingestion without system collapse
- Operational metrics separating “bytes moved” from “assets usable”
- Leadership narrative to align IT, informatics, and R&D stakeholders
Complete the form below to receive Part 1 of the white paper series.
